Keynote, Invited and Guest Speakers for 2025
The BAD Conference & Events Committee is extremely grateful to the contribution of the Keynote, Invited and Guest lecturers that attend the BAD Annual Meeting speaking in the Plenary and concurrent sessions. Some are familiar BAD Members, whilst others are from outside both the association and the specialty. All offer an invaluable educational benefit to our members and we are very thankful.
Details will appear here shortly on the Keynote and Invited Lecturers for the 2025 Annual Meeting.
Tuesday 1 July – Plenary Speakers
Your Content Goes Here
Graduated in Medicine from Monash University with Honours in 1993
Two years of training as Clinical Research Fellow at Dept of Dermatology, Churchill Hospital, Oxford.
Obtained Fellowship of Australasian College of Dermatologists in 2004
Visiting Dermatologist at the Victorian Melanoma Service, Paula Fox Melanoma and Cancer Centre, Alfred Health, Melbourne since 2005
Authored over 70 publications & co-editor of textbook “Diagnostic Dermoscopy: The Illustrated Guide” (Bowling, Paoli & Chamberlain) 2nd Edition published in 2022
Adjunct Associate Professor, School of Translational Medicine, Monash University
Previous Assistant Editor, Australasian Journal of Dermatology
National Examinations Committee, Australasian College of Dermatologists
Wednesday 2 July – Plenary Speakers
Dr Ashley Wysong is Professor Emeritus and Founding Chair at the University of Nebraska Department of Dermatology. She is an accomplished leader, an internationally recognized Mohs micrographic surgeon, a translational skin cancer researcher, and a dedicated mentor. Dr Wysong obtained her master’s degree in epidemiology at Stanford University and her medical degree at Duke University School of Medicine where she was valedictorian. She completed her residency in dermatology at Stanford University where she was chief resident and her fellowship in Mohs micrographic surgery and Cutaneous Oncology at Scripps Clinic. Dr. Wysong has a broad background in clinical, translational, and outcomes-based research in squamous cell carcinoma and other high-risk skin cancers.
Hayley is a Consultant Dermatologist & Dermatological Surgeon at the Royal Free NHS Trust in Hampstead, London. Hayley has expertise in early detection of Skin cancer, Mohs surgery and Cosmetic dermatology. She is Secretary of the BCDG and co-director of the national Injectables course with a passion for improving cosmetic training for dermatologists in the UK. Hayley has undertaken numerous procedural fellowships internationally including the Netherlands & the USA.
Dr Aveen Connolly is a UK-trained consultant dermatologist. She completed her dermatology training at St John’s Institute of Dermatology within Guy’s and St Thomas’ and King’s College Hospital, London, and currently practices between the Royal Free and King’s College Hospitals in London.
Dr Connolly’s primary research interests focus on connective tissue diseases involving the skin and hair, including lupus, dermatomyositis, and scleroderma. She was awarded the prestigious Louis Forman Fellowship by the Royal Society of Medicine and the British Skin Foundation, which she successfully completed with rheumatology, in 2023. Dr Connolly is also actively involved in several clinical trials at King’s College Hospital, with a focus on connective tissue diseases.
She has published extensively and presented at both national and international conferences, earning numerous accolades for her work. A passionate advocate for medical education, Dr Connolly serves as the Associate Editor for Clinical and Experimental Dermatology (CED).
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Dr Helen Lotery MD FRCP FRCPI MRCGP is a consultant dermatologist in Southampton with particular interest in vulval dermatology and in medical education.
After initially training as a GP in Northern Ireland, she spent 3 years in a clinical and research fellowship in vulval disease at the University of Iowa. She moved to Southampton in 2002, trained in dermatology on the Wessex SpR rotation and has been a consultant in University Hospital Southampton NHS Foundation Trust since 2007 and an Honorary Principal Teaching Fellow at the University of Southampton. She leads the multidisciplinary vulval service, and the vulva remains her chosen specialised subject.
Thursday 3 July – Plenary Speakers
David Bick MD is the Principal Clinician for the Newborn Genomes Programme at Genomics England. Prior to his work in England, he was the Chief Medical Officer and a faculty investigator at the HudsonAlpha Institute for Biotechnology. Dr. Bick also served as the Medical Director of the Smith Family Clinic for Genomic Medicine at HudsonAlpha and the Laboratory Director of the HudsonAlpha Clinical Services Laboratory.
He came to HudsonAlpha from the Medical College of Wisconsin where he was Professor in the Department of Pediatrics and the Department of Obstetrics & Gynecology and Director of the Clinical Sequencing Laboratory, Director of the Advanced Genomics Laboratory, Medical Director of the Genetics Clinic at Children’s Hospital of Wisconsin, and Chief of the Division of Genetics in the Department of Pediatrics at Medical College of Wisconsin. Dr. Bick is board certified in Pediatrics, Clinical Genetics, and Clinical Molecular Genetics.
Dr. Bick has published numerous peer-reviewed articles, chapters, and reviews. His laboratories at the Medical College of Wisconsin and Children’s Hospital of Wisconsin were the first in the world to offer whole genome sequencing as a clinical test. He also developed the first Genomic Medicine Clinic in the United States.
Tuesday 1 July – Special Interest Group Speakers
Speaker TBC
Dr Ashley Wysong
Dr Ashley Wysong is Professor Emeritus and Founding Chair at the University of Nebraska Department of Dermatology. She is an accomplished leader, an internationally recognized Mohs micrographic surgeon, a translational skin cancer researcher, and a dedicated mentor. Dr Wysong obtained her master’s degree in epidemiology at Stanford University and her medical degree at Duke University School of Medicine where she was valedictorian. She completed her residency in dermatology at Stanford University where she was chief resident and her fellowship in Mohs micrographic surgery and Cutaneous Oncology at Scripps Clinic. Dr. Wysong has a broad background in clinical, translational, and outcomes-based research in squamous cell carcinoma and other high-risk skin cancers.
Wednesday 2 July – Special Interest Group Speakers
Dr Helen Hanson
Dr Helen Hanson is a Consultant in Cancer Genetics at the Peninsula Regional Genetics Service at the Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK and holds an NIHR Senior Investigator Fellowship at the Exeter NIHR Biomedical Research Centre.
Dr Hanson qualified in medicine in 2002 from Guy’s, Kings and St Thomas’ Medical School, London and became a member of the Royal College of Physicians in 2005 and a Fellow in 2017. She completed her Clinical Genetics Training at St. George’s Hospital and Guy’s Hospital and has previously been a Consultant at the Royal Marsden and St. George’s Hospital in London, before taking up her current post in September 2023.
Dr Hanson is the outgoing Chair of the UK Cancer Genetics Group and has a strong clinical and research interest in improving the diagnosis and management of individuals with an inherited predisposition to cancer. She has collaborated nationally and internationally in the development of clinical guidelines for individuals with inherited cancer predisposition, including BAP1 and POT1, set up a National Cancer Genetics MDT and led development and implementation of a National Inherited Cancer Predisposition Register in England.
Speaker TBC
Speaker TBC
Speaker TBC
Thursday 3 July – Special Interest Group Speakers
